• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: C.R. BARD, INC. (BASD) -3006260740 ACCUCATH INTRAVASCULAR CATHETER 20 GX2.25; CATHETER,INTRAVASCULAR,THERAPEUTIC,SHORT-TERM LESS THAN 30 DAYS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

C.R. BARD, INC. (BASD) -3006260740 ACCUCATH INTRAVASCULAR CATHETER 20 GX2.25; CATHETER,INTRAVASCULAR,THERAPEUTIC,SHORT-TERM LESS THAN 30 DAYS Back to Search Results
Model Number N/A
Medical Device Problem Code Activation Problem (4042)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 11/13/2021
Type of Reportable Event Malfunction
Event or Problem Description
It was reported "accucath needle would not retract when safety activated post guidewire deployment.Needle manually removed from catheter once inserted into patient, and retracted into safety casing used gravity.".
 
Additional Manufacturer Narrative
The device has not been returned to the manufacturer for evaluation.A lot history review (lhr) of refw1505 showed no other similar product complaint(s) from this lot number.
 
Event or Problem Description
It was reported "accucath needle would not retract when safety activated post guidewire deployment.Needle manually removed from catheter once inserted into patient, and retracted into safety casing used gravity.".
 
Event or Problem Description
It was reported "accucath needle would not retract when safety activated post guidewire deployment.Needle manually removed from catheter once inserted into patient, and retracted into safety casing used gravity.".
 
Additional Manufacturer Narrative
H11: section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.The following were reviewed as part of this investigation: patient severity, trend analysis, applicable previous investigation(s), sample (if available), and applicable fmea documents.Based on a review of this information, the following was concluded: the complaint of safety mechanism failure was confirmed and the cause appeared to be manufacturing related.The product returned for evaluation was one 20ga x 2.25¿ accucath peripheral iv catheter assembly.Light usage residues were observed.The catheter had been advanced and was not returned for evaluation.The safety button was depressed and the needle was fully withdrawn into the housing.The spring was compressed and attached to the needle carrier.Microscopic inspection of the device confirmed that the spring was compressed and attached to the needle carrier.The needle was exposed by gently shaking the housing while held upside down.The lack of spring engagement with the top of the needle housing prevented the safety from functioning as intended.The spring appeared to be adhered to the needle carrier, which likely occurred during device assembly.Photographs have been forwarded to the manufacturing site for further evaluation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ACCUCATH INTRAVASCULAR CATHETER 20 GX2.25
Common Device Name
CATHETER,INTRAVASCULAR,THERAPEUTIC,SHORT-TERM LESS THAN 30 DAYS
Manufacturer (Section D)
C.R. BARD, INC. (BASD) -3006260740
605 north 5600 west
salt lake city 84116
Manufacturer (Section G)
BARD REYNOSA S.A. DE C.V. -9617592
blvd. montebello #1
parque industrial colonial
reynosa, tamaulipas 88780
MX   88780
Manufacturer Contact
kelsey erickson
605 north 5600 west
salt lake city 84116
8015950700
MDR Report Key12910452
Report Number3006260740-2021-05085
Device Sequence Number14723803
Product Code FOZ
UDI-Device Identifier00801741110948
UDI-Public(01)00801741110948
Combination Product (Y/N)N
Initial Reporter StateGA
Initial Reporter CountryUS
PMA/510(K) Number
K153298
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Other,Company Representative
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup
Report Date (Section B) 03/23/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model NumberN/A
Device Catalogue NumberAC0202250
Device Lot NumberREFW1505
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 11/14/2021
Supplement Date Received by Manufacturer12/07/2021
03/23/2022
Initial Report FDA Received Date12/01/2021
Supplement Report FDA Received Date12/17/2021
03/30/2022
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured09/01/2021
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient Age69 YR
Patient SexMale
Patient Weight63 KG
-
-